Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
This study evaluated the effects of Dulaglutide on weight loss in a morbidly obese patient with type 2 diabetes, resulting in significant weight reduction and improved glycemic control.
This study compared the effects of empagliflozin and pioglitazone on echocardiographic indices in patients with type 2 diabetes and nonalcoholic fatty liver disease, finding significant improvements in certain measures.
This study evaluated the effects of empagliflozin on diastolic function in patients with type 2 diabetes and elevated end-diastolic pressure, finding significant improvements in various cardiovascular and metabolic parameters.
This study tested the SGLT2 inhibitor empagliflozin in 79 people with type 2 diabetes and early kidney disease over 24 weeks. While empagliflozin showed early improvements in albumin excretion at 4 and 12 weeks, the difference was not significant by 24 weeks. However, it did reduce certain hypoxia-related proteins in the blood that may contribute to kidney damage.
A family-oriented mHealth intervention including 24 videos on T2D self-management and behavioral techniques.
This study evaluated the impact of green tea extract on glycemic and lipid profiles in patients with type 2 diabetes, finding significant improvements in several metabolic markers.
This study explored a machine learning framework for predicting postprandial glycemic events in individuals with Type 1 Diabetes, demonstrating reductions in both hypoglycemia and hyperglycemia incidences.
This study investigated the effects of magnesium and potassium supplementation on cholesterol levels and quality of life in patients with type 2 diabetes mellitus, finding significant improvements in both areas.
This study explored a digital health intervention aimed at women with gestational diabetes in Vietnam, focusing on various health outcomes.
This study explored a digital intervention for emerging adults with Type 1 diabetes, finding improvements in diabetes knowledge and self-efficacy.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
